Arthur Epstein
Corneal and Contact Management · Phoenix, AZNPI 1427038249
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $180,477 of the $278,992 with a category attached, or 64.7%. 23 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 36.2% of the total. Reporting peaked in 2020 at $125,510 and has fallen 90.2% since, to $12,271 in 2022.
Across 327 payments — averaging $853.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb, A Division Of Bausch Health US, LLC$101K
- Novartis$56K
- Lumenis, Inc$31K
- Shire North American Group Inc$24K
- Sight Sciences, Inc.$17K
- Bausch & Lomb Americas Inc.$11K
- plus $39K from 17 others
Across 8 payments — averaging $30,525 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$140K
- Johnson & Johnson Surgical Vision, Inc.$105K
What the payments were for
- Consulting fees$76,34127%
- Speaking & faculty fees$180,47765%
- Travel & lodging$16,3466%
- Food & beverage$5,8282%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 62 | $100,915 |
| Novartis | 68 | $55,582 |
| Lumenis, Inc | 5 | $30,954 |
| Shire North American Group Inc | 43 | $24,017 |
| Sight Sciences, Inc. | 33 | $17,368 |
| Bausch & Lomb Americas Inc. | 11 | $11,170 |
| Sun Pharmaceutical Industries Inc. | 31 | $8,428 |
| Johnson & Johnson Surgical Vision, Inc. | 8 | $6,934 |
| Alcon | 17 | $6,221 |
| AbbVie | 7 | $4,927 |
| Kala Pharmaceuticals, Inc. | 16 | $4,431 |
| Biotissue Holdings Inc. | 2 | $2,116 |
| Oculus, Inc. | 1 | $2,000 |
| Lumenis Ltd. | 1 | $1,500 |
| Lumenis (germany) GmbH | 1 | $1,500 |
| Dompe US, Inc. | 10 | $715 |
| Coopervision Inc. | 5 | $96 |
| Aerie Pharmaceuticals, Inc. | 1 | $25 |
| The Walman Optical Company | 1 | $24 |
| Maculogix, Inc. | 1 | $22 |
| Akorn Operating Company LLC | 1 | $18 |
| Quidel Corporation | 1 | $18 |
| Johnson & Johnson Vision Care, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ULTRA$86,803
- BIOTRUE$76,565
- XIIDRA$64,990
- BIOTRUE ONE DAY$18,312
- TearCare$13,147
- Lumenis Pulse 120H$10,992
- LOTEMAX SM$7,850
- CEQUA$7,820
- PAZEO$6,300
- EYSUVIS$4,118
- TearCare SmartLid$3,500
- TEARCARE(TM) (2.2) SYSTEM KIT$3,500
- One Series Ultra IOL Delivery System$3,330
- ILUX$2,336
- Prokera$2,100
- AmnioGraft$2,100
- AmnioGuard$2,100
- OCULUS Keratograph 5M$2,000
- optilight$1,500
- ZYLET$1,123
How this compares
Too few corneal and contact management providers in Arizonato place this figure against a meaningful peer group, so we don't.
Other corneal and contact management in Phoenix
- David AndersonPhoenix$5K
- Timothy McAuliffePhoenix$3K
- Ljiljana AleksicPhoenix$3K
- Howard RosnerPhoenix$378
- Caitlin MorrisonScottsdale$90K
- Brianna RyffGlendale$15K
- Nha CaoScottsdale$7K
- Erik BurnettTucson$4K
- Bartholomew PembertonTucson$4K
- Andrew HuttenhoffTucson$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.